HCAR1 and brain injury: In light of these results, we consider that even though HCAR1 activation might not be considered as a promising pharmacological strategy to treat acute brain injuries such as stroke, it would be interesting to further investigate lactate’s mechanisms of neuroprotection, in particular, those related to its metabolic roles and how HCAR1 contributes to the ischemic injury.